TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation
Learn more about:
Related Clinical Trial
Evaluation of Botulinum TOXin Type A in the Treatment of Buerger’s Disease
Individual Patient Expanded Access IND for Selexipag (Uptravi) in Participants With Non-healing Wound, Buerger’s Disease
Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia
TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation
Contrast Enhanced Ultrasound and Muscle
Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia
Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Buerger’s Disease
Treatment of Thromboangiitis Obliterans (Buerguer’s Disease) With Bosentan
A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease